SCHEMBL10082964

SCHEMBL10082964

N=c1ccc2c(-c3cc(C(=O)O)ccc3C(=O)O)c3ccc(N)cc3oc-2c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.59
USP2 O75604 4/20 0.57
ATM Q13315 2/20 0.57
CFTR P13569 1/20 0.57
PAX8 Q06710 1/20 0.57
GOPC Q9HD26 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.53
DNASE1L3 Q13609 1/20 0.42
PRMT1 Q99873 1/20 0.42
MEN1 O00255 2/20 0.41
POLB P06746 2/20 0.41
KMT2A Q03164 2/20 0.41
ALPL P05186 1/20 0.41
ALPI P09923 1/20 0.41
ALPG P10696 1/20 0.41
CA9 Q16790 3/20 0.36
ALB P02768 1/20 0.35
CA1 P00915 2/20 0.35
CA2 P00918 2/20 0.35
PLEC Q15149 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29483446 0.92 ABCB1 (0.63) ABCB1USP2ATMCFTRPAX8
SCHEMBL14627720 0.92 ABCB1 (0.63) ABCB1USP2ATMCFTRPAX8
SCHEMBL23182124 0.90 ABCB1 (0.59) ABCB1USP2ATMCFTRPAX8
SCHEMBL17695458 0.88 ABCB1 (0.61) ABCB1USP2ATMCFTRPAX8
SCHEMBL7959938 0.88 USP2 (0.68) ABCB1USP2ATMCFTRPAX8
SCHEMBL23182127 0.88 ABCB1 (0.58) ABCB1USP2ATMCFTRPAX8
SCHEMBL458205 0.87 ABCB1 (0.77) ABCB1USP2ATMCFTRPAX8
SCHEMBL12964718 0.86 ABCB1 (0.56) ABCB1USP2ATMCFTRPAX8
SCHEMBL19269178 0.86 ABCB1 (0.59) ABCB1USP2ATMCFTRPAX8
Hydrochloric Acid SCHEMBL5606345 0.86 USP2 (0.76) ABCB1USP2ATMCFTRPAX8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025061863-A1 METHOD BioNTech SE (DE) 2025-03-27 WO disclosed
US-11655504-B2 High intensity labeled reactant compositions and methods for sequencing Quantum-Si Incorporated (US) 2023-05-23 US disclosed
US-9068985-B2 Fluorescent labeling of living cells EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2015-06-30 US disclosed
WO-2014200872-A9 PHARMACEUTICAL COMPOUNDS TARGETED BY MIF AFFINITY-TETHERED MOIETIES RJS BIOLOGICS LLC (US) 2015-02-05 WO disclosed
WO-2014200872-A1 PHARMACEUTICAL COMPOUNDS TARGETED BY MIF AFFINITY-TETHERED MOIETIES RJS BIOLOGICS LLC (US) 2014-12-18 WO disclosed
US-20140206840-A1 FLUORESCENT LABELING OF LIVING CELLS EMPIRE TECHNOLOGY DEVELOPMENT LLC (US) 2014-07-24 US disclosed
US-20120016128-A1 Rhodamine lactone phosphoramidites and polymers AAT BIOQUEST, INC. 2012-01-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120016128-A1 Rhodamine lactone phosphoramidites and polymers PHYKPL, PFAS, PHOSPHO1 ABCB1 2094/4885USP2 4450/4885ATM 3736/4885
US-11655504-B2 High intensity labeled reactant compositions and methods for sequencing NSUN2, FBL, DNMT3A ABCB1 3487/4885USP2 3689/4885ATM 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.